Poland· PL-100489540
Posela
A ivermectin product containing ivermectinum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ivermectin is registered in 15 of 19 countries.
Countries holding a registration under ATC P02CF01 (ivermectin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Ivermectin · ATC P02CF01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Ivermectinum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- P02CF01
- ATC class
- Ivermectin
- Defined daily dose
- 12 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 5
- gtin05909991525507
- gtin05909991525514
- gtin05909991525521
- gtin05909991525538
- gtin05909991525545
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
111 interactions on record for ivermectin.
Graded by severity as the source publishes them — 84 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ivermectin · interactions on record
111 records
- 84 moderate
- 2 minor
- 25 info
Most severe, free to view
- AprepitantA04AD12moderate
- LonafarnibA16AX20moderate
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ivermectin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaIVERMEKTIN ARISTOAristo Pharma GmbH, Berlin
- NetherlandsIvergalen 3 mg, tablettenGalenicum Derma S.L.U.
- FranceIVERMECTINE ARROW LAB 3 mg, compriméARROW GENERIQUES
- United StatesivermectinEPIC PHARMA LLC
- FinlandIvermectin GlenmarkGlenmark Arzneimittel GmbH
- United KingdomIvermectin 3mg tabletsZydus Pharmaceuticals UK Ltd
- SpainIVERCARE 3 MG COMPRIMIDOS EFGIndustrial Farmaceutica Cantabria S.A.
- NorwayIvermectin GlenmarkGlenmark Arzneimittel GmbH
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Ivergelan, Ivermectin Stada
- Belgium · Cesora, Ivermectin Eg
- Bulgaria · Ивермектин, Скабал
- Cyprus · Scaball, Soolantra
- Czechia · Ivermektin Aristo, Loutol
- Germany · Driponin, Iveraxiro
- Denmark · Ivermectin Medical Valley, Ivermectin Newbury
- Estonia · Ivermectin Orion, Soolantra
- Spain · Ivercare, Ivergalen
- Finland · Ivermectin Glenmark, Ivermectin Medical Valley
- France · Bibovel, Cesora
- United Kingdom (Northern Ireland) · Ivermectin, Ivermectin Aristo
- Greece · Scaball, Soolantra
- Hungary · Soolantra
- Ireland · Iverscab, Soolantra
- Iceland · Ivermcetin Stada, Ivermectin Medical Valley
- Italy · Efacti, Ivercare
- Lithuania · Ivermectin Orion, Soolantra
- Luxembourg · Ivermectin Eg, Ivermectin Substipharm
- Latvia · Ivermectin Orion, Ivermectine Orion
- Malta · Soolantra
- Netherlands · Ivergalen, Ivermectin Substipharm
- Norway · Ivermectin Glenmark, Ivermectin Medical Valley
- Portugal · Ivergalen, Ivermectina Cantabria
- Romania · Soolantra
- Sweden · Cesora, Efrinter
- Slovakia · Ivermectin Exeltis, Soolantra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd683203-2a65-41f2-8177-59e51b93f35b GET /v1/drugs/fd683203-2a65-41f2-8177-59e51b93f35b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "3 mg",
"packaging": "05909991525507 ¦ Rp ¦ 151918\n8 tabl.\n05909991525514 ¦ Rp ¦ 151919\n16 tabl.\n05909991525521 ¦ Rp ¦ 151920\n20 tabl.\n05909991525538 ¦ Rp ¦ 151921\n4 tabl.\n05909991525545 ¦ Rp ¦ 151922\n12 tabl.",
"substance": "Ivermectinum 3 mg",
"common_name": "Ivermectinum",
"pl_product_id": "100489540",
"pozwolenie_nr": "254/23",
"auth_procedure": "IR",
"authorisation_validity": "2028-11-07"
}See everything about ivermectin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.